Alzheimer's disease (AD) presents a significant challenge in healthcare, prompting exploration into non-pharmacological interventions to complement traditional treatments.
Objective
This systematic review explores the efficacy of lifestyle-based interventions in managing AD.
Methods
A comprehensive literature search was conducted in PubMed, Web of Science, and Scopus between 2018 and 2023, selecting randomized controlled trials examining factors such as exercise, diet, stress, and cognitive training in AD patients.
Results
The review revealed physical exercise as the predominant non-pharmacological intervention, accompanied by dietary modifications, cognitive training, and therapies such as mindfulness and music. While exercise demonstrated improvements in quality of life, its cognitive benefits were limited. Modified diets, such as Atkins and ketogenic, displayed inconsistent effects on cognitive function but influenced other health-related parameters. Additionally, probiotic therapy and novel cognitive training technologies were explored.
Conclusions
Despite some interventions showing promise in enhancing cognitive function and slowing disease progression, uncertainties remain regarding the dose-response relationship, underlying mechanisms, and potential synergistic effects. Moreover, consideration of genetic and sex-based disparities is warranted. This synthesis underscores the need for further research to elucidate the nuances of non-pharmacological interventions in managing AD effectively.
2023 Alzheimer’s disease facts and figures. Alzheimers Dement2023; 19: 1598–1695.
2.
BreijyehZKaramanR. Comprehensive review on Alzheimer’s disease: causes and treatment. Molecules2020; 25: 5789.
3.
DuZLiYLiJ, et al.Physical activity can improve cognition in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials. Clin Interv Aging2018; 13: 1593.
4.
BriniSSohrabiHRPeifferJJ, et al.Physical activity in preventing Alzheimer’s disease and cognitive decline: a narrative review. Sports Med2018; 48: 29–44.
5.
PeterssonSDPhilippouE. Mediterranean Diet, cognitive function, and dementia: a systematic review of the evidence. Adv Nutr2016; 7: 889–904.
6.
GuarnieriLBoscoFLeoA, et al.Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer’s disease. Ageing Res Rev2024; 95: 102210.
7.
BeversdorfDQCrosbyHWShenkerJI. Complementary and alternative medicine approaches in Alzheimer disease and other neurocognitive disorders. Mo Med2023; 120: 70–78.
8.
KelleyBJKnopmanDS. Alternative medicine and Alzheimer disease. Neurologist2008; 14: 299–306.
9.
PageMJMcKenzieJEBossuytPM, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ2021; 372: 71.
10.
RichardsonWSWilsonMCNishikawaJ, et al.The well-built clinical question: a key to evidence-based decisions. ACP J Club1995; 123: A12–A13.
11.
OremusMWolfsonCPerraultA, et al.Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer’s disease drug trials. Dement Geriatr Cogn Disord2001; 12: 232–236.
12.
ZhangYZhouLLiuX, et al.The effectiveness of the problem-based learning teaching model for use in introductory Chinese undergraduate medical courses: a systematic review and meta-analysis. PLoS One2015; 10: e0120884.
13.
AngiolilloALecceseDCiccotelliS, et al.Effects of Nordic walking in Alzheimer’s disease: a single-blind randomized controlled clinical trial. Heliyon2023; 9: e15865.
14.
Ben AyedICastor-GuyonvarchNAmimourS, et al.Acute exercise and cognitive function in Alzheimer’s disease. J Alzheimers Dis2021; 82: 749–760.
15.
de C CezarNOAnsaiJHde AndradeLP. Home-based multimodal exercise program in older people with Alzheimer disease: randomized controlled trial protocol. Physiother Res Int2021; 26: e1899.
16.
ChenLLiHChenX, et al.Effects of hand exercise on eating action in patients with Alzheimer’s disease. Am J Alzheimers Dis Other Demen2019; 34: 57–62.
17.
ChortaneOGHammamiRAmaraS, et al.Effects of multicomponent exercise training program on biochemical and motor functions in patients with Alzheimer’s dementia. Sustainability2022; 14: 4112.
18.
de Oliveira SilvaFFerreiraJPlácidoJ, et al.Three months of multimodal training contributes to mobility and executive function in elderly individuals with mild cognitive impairment, but not in those with Alzheimer’s disease: a randomized controlled trial. Maturitas2019; 126: 28–33.
19.
EnetteLVogelTMerleS, et al.Effect of 9 weeks continuous vs. Interval aerobic training on plasma BDNF levels, aerobic fitness, cognitive capacity and quality of life among seniors with mild to moderate Alzheimer’s disease: a randomized controlled trial. Eur Rev Aging Phys Act2020; 17: 2.
20.
FrederiksenKLarsenCHasselbalchS, et al.A 16-week aerobic exercise intervention does not affect hippocampal volume and cortical thickness in mild to moderate Alzheimer’s disease. Front Aging Neurosci2018; 10: 293.
21.
FrederiksenKMadsenKAndersenB, et al.Moderate- to high-intensity exercise does not modify cortical β-amyloid in Alzheimer’s disease. Alzheimers Dement (NY)2019; 5: 208–215.
22.
FrederiksenKJensenCHøghP, et al.Aerobic exercise does not affect serum neurofilament light in patients with mild Alzheimer’s disease. Front Neurosci2023; 17: 1108191.
23.
FonteCSmaniaNPedrinollaA, et al.Comparison between physical and cognitive treatment in patients with MCI and Alzheimer’s disease. Aging (Albany NY)2019; 11: 3138–3155.
24.
JensenCBahJMØstergaardL, et al.Exercise as a potential modulator of inflammation in patients with Alzheimer’s disease measured in cerebrospinal fluid and plasma. Exp Gerontol2019; 121: 91–98.
25.
JensenCSMusaeusCSFrikke-SchmidtR, et al.Physical exercise may increase plasma concentration of high-density lipoprotein-cholesterol in patients with Alzheimer’s disease. Front Neurosci2020; 14: 532.
26.
LamLChanWKwokT, et al.Combined physical exercise-working memory training on slowing down cognitive decline in elders with mild clinical Alzheimer disease: a randomised controlled study (abridged secondary publication). Hong Kong Med J2022; 28 Suppl 3: 28–30.
27.
LanzaGCentonzeSSDestroG, et al.Shiatsu as an adjuvant therapy for depression in patients with Alzheimer’s disease: a pilot study. Complement Ther Med2018; 38: 74–78.
28.
LokNTosunASLokS, et al.Effect of physical activity program applied to patients with Alzheimer’s disease on cognitive functions and depression level: a randomised controlled study. Psychogeriatrics2023; 23: 856–863.
29.
MenengiçKNYeldanİCınarN, et al.Effectiveness of home-based telerehabilitation in mild to moderate Alzheimer’s disease: a randomized controlled study. Alzheimers Dement2021; 17 Suppl 8: e053406.
30.
MinNSGilKS. Dual-task training effect on cognitive and body function, β-amyloid levels in Alzheimer’s dementia patients: a randomized controlled trial. J Korean Soc Phys Ther2021; 33: 136–141.
31.
MusaeusCJohansenLHasselbalchS, et al.Sixteen weeks of aerobic exercise does not alter resting-state connectivity of the precuneus in patients with Alzheimer’s disease. Curr Alzheimer Res2022; 19: 171–177.
32.
NagyENAliAYBehiryME, et al.Impact of combined photo-biomodulation and aerobic exercise on cognitive function and quality-of-life in elderly Alzheimer patients with anemia: a randomized clinical trial. Int J Gen Med2021; 14: 141–152.
33.
Orcioli-SilvaDBarbieriFASimieliL, et al.A program of physical activity improves gait impairment in people with Alzheimer’s disease. Motriz2018; 24: e101864.
34.
PapatsimpasVVrouvaSPapathanasiouG, et al.Does therapeutic exercise support improvement in cognitive function and instrumental activities of daily living in patients with mild Alzheimer’s disease? A randomized controlled trial. Brain Sci2023; 13: 1112.
35.
ParvinEMohammadianFAmani-ShalamzariS, et al.Dual-task training affect cognitive and physical performances and brain oscillation ratio of patients with Alzheimer’s disease: a randomized controlled trial. Front Aging Neurosci2020; 12: 605317.
36.
PedrinollaAVenturelliMFonteC, et al.Exercise training improves vascular function in patients with Alzheimer’s disease. Eur J Appl Physiol2020; 120: 2233–2245.
37.
PerttilaNMÖhmanHStrandbergTE, et al.Effect of exercise on drug-related falls among persons with Alzheimer’s disease: a secondary analysis of the FINALEX study. Drugs Aging2018; 35: 1017–1023.
38.
RoittoHKautiainenHÖhmanH, et al.Relationship of neuropsychiatric symptoms with falls in Alzheimer’s disease - does exercise modify the risk?J Am Geriatr Soc2018; 66: 2377–2381.
39.
SalisburyDMathiasonMAYuF. Exercise dose and aerobic fitness response in Alzheimer's dementia: findings from the FIT-AD trial. Int J Sports Med2022; 43: 850–858.
40.
ShawICronjeMShawBS. Group-based exercise as a therapeutic strategy for the improvement of mental outcomes in mild to moderate Alzheimer’s patients in low resource care facilities. Asian J Sports Med2021; 12: e106593.
41.
SobolNADallCHHøghP, et al.Change in fitness and the relation to change in cognition and neuropsychiatric symptoms after aerobic exercise in patients with mild Alzheimer’s disease. J Alzheimers Dis2018; 65: 137–145.
42.
TodriJLenaOMartínez GilJL. A single blind randomized controlled trial of global postural re-education: cognitive effects on Alzheimer disease patients. Eur J Psychiatry2019; 33: 83–90.
43.
TodriJTodriALenaO. Why not a global postural reeducation as an alternative therapy applied to Alzheimer’s patients in nursing homes? A pioneer randomized controlled trial. Dement Geriatr Cogn Disord2020; 48: 172–179.
44.
TodriJLenaOMartínez GilJ. An experimental pilot study of global postural reeducation concerning the cognitive approach of patients with Alzheimer’s disease. Am J Alzheimers Dis Other Demen2020; 35: 1533317519867824.
45.
van der KleijLPetersenESiebnerH, et al.The effect of physical exercise on cerebral blood flow in Alzheimer’s disease. Neuroimage Clin2018; 20: 650–654.
46.
VidoniEDPeralesJAlshehriM, et al.Aerobic exercise sustains performance of instrumental activities of daily living in early-stage Alzheimer disease. J Geriatr Phys Ther2019; 42: E129–E134.
47.
YangZZhangWLiuD, et al.Effects of sport stacking on neuropsychological, neurobiological, and brain function performances in patients with mild Alzheimer’s disease and mild cognitive impairment: a randomized controlled trial. Front Aging Neurosci2022; 14: 910261.
48.
YuFVockDMZhangL, et al.Cognitive effects of aerobic exercise in Alzheimer’s disease: a pilot randomized controlled trial. J Alzheimers Dis2021; 80: 233–244.
49.
YuFMathiasonMAHanS, et al.Mechanistic effects of aerobic exercise in Alzheimer’s disease: imaging findings from the pilot FIT-AD trial. Front Aging Neurosci2021; 13: 703691.
50.
YuFSalisburyDMathiasonMA. Inter-individual differences in the responses to aerobic exercise in Alzheimer’s disease: findings from the FIT-AD trial. J Sport Health Sci2021; 10: 65–72.
51.
YuFHanSYSalisburyD, et al.Feasibility and preliminary effects of exercise interventions on plasma biomarkers of Alzheimer’s disease in the FIT-AD trial: a randomized pilot study in older adults with Alzheimer’s dementia. Pilot Feasibility Stud2022; 8: 243.
52.
YunJKimDChangM. A simple bedside exercise method to enhance lower limb muscle strength in moderate Alzheimer’s disease patients with sarcopenia. Healthcare (Basel)2021; 9: 680.
53.
AgahiAHamidiGADaneshvarR, et al.Does severity of Alzheimer’s disease contribute to its responsiveness to modifying gut microbiota? A double blind clinical trial. Front Neurol2018; 9: 662.
54.
AkhgarjandCVahabiZShab-BidarS, et al.Effects of probiotic supplements on cognition, anxiety, and physical activity in subjects with mild and moderate Alzheimer’s disease: a randomized, double-blind, and placebo-controlled study. Front Aging Neurosci2022; 14: 1032494.
55.
BrandtJBuchholzAHenry-BarronB, et al.Preliminary report on the feasibility and efficacy of the modified Atkins diet for treatment of mild cognitive impairment and early Alzheimer’s disease. J Alzheimers Dis2019; 68: 969–981.
56.
ChenHLiuSGeB, et al.Effects of folic acid and vitamin B12 supplementation on cognitive impairment and inflammation in patients with Alzheimer’s disease: a randomized, single-blinded, placebo-controlled trial. J Prev Alzheimers Dis2021; 8: 249–256.
57.
ForoumandiEJavanRMoayedL, et al.The effects of fenugreek seed extract supplementation in patients with Alzheimer’s disease: a randomized, double-blind, placebo-controlled trial. Phytother Res2023; 37: 285–294.
58.
JernerénFCederholmTRefsumH, et al.Homocysteine status modifies the treatment effect of omega-3 fatty acids on cognition in a randomized clinical trial in mild to moderate Alzheimer’s disease: the OmegAD study. J Alzheimers Dis2019; 69: 189–197.
59.
JiaJHuJHuoX, et al.Effects of vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer’s disease: a randomised, double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry2019; 90: 1347–1352.
60.
KainumaMOumaSKawakatsuS, et al.An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer’s disease. Front Pharmacol2022; 13: 991982.
61.
LiI-CChangH-HLinC-H, et al.Prevention of early Alzheimer’s disease by erinacine A-enriched Hericium erinaceus mycelia: pilot double-blind placebo-controlled study. Front Aging Neurosci2020; 12: 155.
62.
LinPYChengCSatyanarayananSK, et al.Omega-3 fatty acids and blood-based biomarkers in Alzheimer’s disease and mild cognitive impairment: a randomized placebo-controlled trial. Brain Behav Immun2022; 99: 289–298.
63.
MarianettiMPinnaSVenutiA, et al.Olive polyphenols and bioavailable glutathione: promising results in patients diagnosed with mild Alzheimer’s disease. Alzheimers Dement (NY)2022; 8: e12278.
64.
MuangpaisanWWiputhanuphongsPJaisupaN, et al.Effects of water-soluble mangosteen extract on cognitive function and neuropsychiatric symptoms in patients with mild to moderate Alzheimer’s disease (WECAN-AD): a randomized controlled trial. Alzheimers Dement (N Y)2022; 8: e12292.
65.
NolanJMPowerRHowardAN, et al.Supplementation with carotenoids, omega-3 fatty acids, and vitamin E has a positive effect on the symptoms and progression of Alzheimer’s disease. J Alzheimers Dis2022; 90: 233–249.
66.
OtaMMatsuoJIshidaI, et al.Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease. Neurosci Lett2019; 690: 232–236.
67.
PhillipsMCLDeprezLMMortimerGMN, et al.Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease. Alzheimers Res Ther2021; 13: 51.
68.
Sanchez-RomeroLPacheco-MoisesFPMohammedE, et al.Effect of fish oil on oxidative stress markers in patients with probable Alzheimer’s disease. Arch Latinoam Nutr2020; 70: 123–133.
69.
TamtajiORHeidari-SoureshjaniRMirhosseiniN, et al.Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer’s disease: a randomized, double-blind, controlled trial. Clin Nutr2019; 38: 2569–2575.
70.
TofiqAZetterbergHBlennowK, et al.Effects of peroral omega-3 fatty acid supplementation on cerebrospinal fluid biomarkers in patients with Alzheimer’s disease: a randomized controlled trial—The OmegAD study. J Alzheimers Dis2021; 83: 1291–1301.
71.
Torres-MendozaBMGOrtizGGSánchez-RomeroL, et al.Dietary fish oil increases catalase activity in patients with probable Alzheimer’s disease. Nutr Hosp2022; 39: 1364–1368.
72.
VakilianAAhmadiAMHeidariM, et al.Vitamin B12 administration facilitates the antipsychotic and pain-relieving effects of quetiapine in Alzheimer patients with psychotic symptoms. J Ayub Med Coll Abbottabad2021; 33: S744–S751.
73.
WangG-HWangL-HWangC, et al.Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: a pilot study. Medicine (Baltimore)2018; 97: e0636.
74.
WangHLiuNZhangS, et al.Clinical experience in treatment of Alzheimer’s disease with Jiannao Yizhi formula and routine western medicine. Chin J Integr Med2020; 26: 212–218.
75.
XuQZhangYZhangX, et al.Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer’s disease patients with APOE4(-/-): a double-blind, randomized, placebo-controlled crossover trial. Clin Nutr2020; 39: 2092–2105.
76.
YulugBAltayOLiXY, et al.Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomized, double-blinded, placebo-controlled phase-II trial. Transl Neurodegener2023; 12: 4.
77.
Benitez-LugoMLVazquez-MarrufoMPinero-PintoE, et al.Analysis of physical-cognitive tasks including feedback-based technology for Alzheimer’s disorder in a randomized experimental pilot study. J Clin Med2023; 12: 5484.
78.
GeorgopoulouE-NNousiaASiokasV, et al.Computer-based cognitive training vs. paper-and-pencil training for language and cognitive deficits in Greek patients with mild Alzheimer’s disease: a preliminary study. Healthcare (Basel)2023; 11: 443.
79.
JungYHParkSCLeeJH, et al.Effect of internet-based vs. in-person multimodal interventions on patients with mild to moderate Alzheimer’s disease: a randomized, cross-over, open-label trial. Front Public Health2023; 11: 1203201.
80.
LópezCSánchezJLMartínJ. The effect of cognitive stimulation on the progression of cognitive impairment in subjects with Alzheimer’s disease. Appl Neuropsychol Adult2022; 29: 90–99.
81.
NousiaASiokasVAretouliE, et al.Beneficial effect of multidomain cognitive training on the neuropsychological performance of patients with early-stage Alzheimer’s disease. Neural Plast2018; 2018: 2845176.
82.
OliveiraJGamitoPSoutoT, et al.Virtual reality-based cognitive stimulation on people with mild to moderate dementia due to Alzheimer’s disease: a pilot randomized controlled trial. Int J Environ Res Public Health2021; 18: 5290.
83.
TrebbastoniAImbrianoLPoddaL, et al.Cognitive training in patients with Alzheimer’s disease: findings of a 12-month randomized controlled trial. Curr Alzheimer Res2018; 15: 452–461.
84.
WangX-HLuoM-Q. Cognitive training for elderly patients with early Alzheimer’s disease in the Qinghai-Tibet Plateau: a pilot study. World J Clin Cases2022; 10: 8133–8140.
85.
ChenLCaoHWuX, et al.Effects of oral health intervention strategies on cognition and microbiota alterations in patients with mild Alzheimer’s disease: a randomized controlled trial. Geriatr Nurs2022; 48: 103–110.
86.
GiuliettiMVSpatuzziRFabbiettiP, et al.Effects of mindfulness-based interventions (MBIs) in patients with early-stage Alzheimer’s disease: a pilot study. Brain Sci2023; 13: 484.
87.
HarrisonTCBlozisSASchmidtB, et al.Music compared with auditory books: a randomized controlled study among long-term care residents with Alzheimer’s disease or related dementia. J Am Med Dir Assoc2021; 22: 1415–1420.
88.
KimSJLeeSHSuhIB, et al.Positive effect of timed blue-enriched white light on sleep and cognition in patients with mild and moderate Alzheimer’s disease. Sci Rep2021; 11: 10174.
89.
KimYJKimHRJungYH, et al.Effects of electrical automatic massage on cognition and sleep quality in Alzheimer’s disease spectrum patients: a randomized controlled trial. Yonsei Med J2021; 62: 717–725.
90.
LinCHTsengSTChuangYC, et al.Grounding the body improves sleep quality in patients with mild Alzheimer’s disease: a pilot study. Healthcare2022; 10: 581.
91.
LiuMNLiouYJWangWC, et al.Group music intervention using percussion instruments to reduce anxiety among elderly male veterans with Alzheimer disease. Med Sci Monit2021; 27: e928714.
92.
Quintana-HernándezDJRojas-HernándezJSantana-Del PinoA, et al.Mindfulness prevents depression and psychopathology in elderly people with mild to moderate Alzheimer’s disease: a randomized clinical trial. J Alzheimers Dis2023; 91: 471–481.
93.
QuintavallaFCaoSSpinelliD, et al.Effects of dog-assisted therapies on cognitive mnemonic capabilities in people affected by Alzheimer’s disease. Animals (Basel)2021; 11: 1366.
94.
LlaveroFAlejoLBFiuza-LucesC, et al.Exercise training effects on natural killer cells: a preliminary proteomics and systems biology approach. Exerc Immunol Rev2021; 27: 125–141.
95.
OhSChunSHwangS, et al.Vitamin D and exercise are major determinants of natural killer cell activity, which is age- and gender-specific. Front Immunol2021; 12: 594356.
96.
BurtscherJMalletRTBurtscherM, et al.Hypoxia and brain aging: neurodegeneration or neuroprotection?Ageing Res Rev2021; 68: 101343.
97.
DevassyJGLengSGabbsM, et al.Omega-3 polyunsaturated fatty acids and oxylipins in neuroinflammation and management of Alzheimer disease. Adv Nutr2016; 7: 905–916.
98.
QuYHuH-YOuY-N, et al.Association of body mass index with risk of cognitive impairment and dementia: a systematic review and meta-analysis of prospective studies. Neurosci Biobehav Rev2020; 115: 189–198.
ChenCLiaoJXiaY, et al.Gut microbiota regulate Alzheimer’s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut2022; 71: 2233–2252.
101.
CerdáBTornero-AguileraJFPérezM, et al.Gut microbiota modification: another piece in the puzzle of the benefits of physical exercise in health?Front Physiol2016; 7: 51.
102.
OrnishDMadisonCKivipeltoM, et al.Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial. Alzheimers Res Ther2024; 16: 122.
103.
JackCRJrAndrewsSJBeachTG, et al.Revised criteria for the diagnosis and staging of Alzheimer's disease. Nat Med2024; 30: 2121–2124.
104.
FregniFImamuraMChienHF, et al.International placebo symposium working group. Challenges and recommendations for placebo controls in randomized trials in physical and rehabilitation medicine: a report of the international placebo symposium working group. Am J Phys Med Rehabil2010; 89: 160–172.
105.
HurstPBeedieC. Placebo Effects in Sport and Exercise, 1st ed. New York: Routledge, 2023.
106.
StaudacherHMIrvingPMLomerMCE, et al.The challenges of control groups, placebos and blinding in clinical trials of dietary interventions. Proc Nutr Soc2017; 76: 203–212.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
